SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 3,764.68 |
Enterprise Value ($M) | 3,010.18 |
Book Value ($M) | 1,711.36 |
Book Value / Share | 4.75 |
Price / Book | 2.33 |
NCAV ($M) | 1,154.66 |
NCAV / Share | 3.21 |
Price / NCAV | 3.37 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.04 |
Return on Assets (ROA) | -0.04 |
Return on Equity (ROE) | -0.04 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.42 |
Current Ratio | 6.63 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,372.17 |
Assets | 1,925.68 |
Liabilities | 217.51 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | n/a |
Operating Income | -179.35 |
Net Income | -75.27 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -142.46 |
Cash from Investing | 20.15 |
Cash from Financing | 20.15 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Chesapeake Partners Management Co Inc/md | 2.58 | -1.53 | |
13D/A | Gotham Green Fund 1, L.p. | 4.59 | ||
13D | Altria Group, Inc. | 55.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
Annual Report – 10-K | ||
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Annual Report – 10-K | ||
CRON / Cronos Group Inc. 10-K – Annual Report – 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
467,467 | 5,245,400 | 8.91 | |
457,087 | 4,573,401 | 9.99 | |
600,385 | 4,463,500 | 13.45 | |
485,016 | 6,358,200 | 7.63 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
CRIS – Curis, Inc. | CRMD – CorMedix Inc. |
CRNX – Crinetics Pharmaceuticals, Inc. | CRSP – CRISPR Therapeutics AG |
CRTX – Cortexyme Inc |
Financial data and stock pages provided by
Fintel.io